Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
149.1 USD | +0.61% | -5.73% | -17.08% |
Financials (USD)
Sales 2024 * | 638M | Sales 2025 * | 740M | Capitalization | 8.33B |
---|---|---|---|---|---|
Net income 2024 * | 45M | Net income 2025 * | 88M | EV / Sales 2024 * | 12.6 x |
Net cash position 2024 * | 284M | Net cash position 2025 * | 420M | EV / Sales 2025 * | 10.7 x |
P/E ratio 2024 * |
255
x | P/E ratio 2025 * |
100
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 93.44% |
Latest transcript on Repligen Corporation
1 day | +0.61% | ||
1 week | -5.73% | ||
1 month | -9.20% | ||
3 months | -23.15% | ||
6 months | -5.19% | ||
Current year | -17.08% |
Managers | Title | Age | Since |
---|---|---|---|
Tony Hunt
CEO | Chief Executive Officer | 60 | 14-04-30 |
Olivier Loeillot
PSD | President | 54 | 23-10-01 |
Jason Garland
DFI | Director of Finance/CFO | 50 | 23-09-24 |
Members of the board | Title | Age | Since |
---|---|---|---|
Karen Dawes
CHM | Chairman | 72 | 05-08-31 |
Director/Board Member | 58 | 14-06-11 | |
Martin Madaus
BRD | Director/Board Member | 64 | 23-02-05 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
2.43% | 5 M€ | -1.80% | - | |
1.01% | 0 M€ | 0.00% | - | |
0.84% | 0 M€ | 0.00% | - | |
0.55% | 2 M€ | -.--% |
Date | Price | Change | Volume |
---|---|---|---|
24-05-31 | 149.1 | +0.61% | 875,140 |
24-05-30 | 148.2 | -2.55% | 702,454 |
24-05-29 | 152.1 | -2.99% | 479,772 |
24-05-28 | 156.8 | -0.89% | 726,710 |
24-05-24 | 158.2 | -0.39% | 362,382 |
Delayed Quote Nasdaq, May 31, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-17.08% | 8.33B | |
-7.16% | 178B | |
-4.86% | 67.04B | |
-4.28% | 47.24B | |
+10.32% | 44.62B | |
+8.14% | 42.5B | |
+15.76% | 29.99B | |
+15.53% | 25.22B | |
-5.88% | 24.14B | |
-5.38% | 23.69B |
- Stock Market
- Equities
- RGEN Stock